Worldwide HealthcareWWH:LSE

1,505
7.00 / 0.46%
8.35k
26.26%
0.5749
Latest price in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Oct 24 2014 10:04 BST.

Total returns on £1000

Fund / BenchmarkChange
PriceWorldwide Healthcare (Ordinary Share)+22.57 %
Worldwide Healthcare (Ordinary Share)+26.93 %
Morningstar's BenchmarkFTSE World+3.06 %
As of Oct 20 2014.

Worldwide Healthcare summary

Shares outstanding47.87m
Market cap718.00m GBP
Total assets843.90m GBP
Total expense ratio1.01%
Day high1,515
Day low1,505
Previous close1,512
Average volume95.88k
YTD Change+21.47 %
Beta0.5749%
Diluted NAV (est)1,603.23
Diluted NAV (last pub)1,569.41
Premium/Discount-5.69 %
Gearing+111.00 %
52-week range
Today
1,179
Nov 13 2013
1,525
Oct 09 2014

As of last trade WWH:LSE traded at 1,505, 1.31 % below its 52-week high of 1,525, set on Oct 09, 2014.

Data delayed at least 15 minutes, as of Oct 24 2014 10:04 BST.

Profile

Management group(s)OrbiMed Capital LLC
AIC sectorSector Specialist: Biotechnology/Life Sciences
ISINGB0003385308
Launch date28 Apr 1995
Share typeOrdinary Share
StructureConventional
Base currencyGBP

Objective

To invest worldwide in pharmaceutical and biotechnology companies with the aim of achieving a high level of capital growth.

Management & contract fees

The Investment Manager, receives a periodic fee equal to 0.65% p.a. of the Company's net asset value. The performance fee amounts to 16.5% of any out-performance of the NAV over the benchmark index.

Dividend

Div yield1.10229
Div ex-date04 Jun 2014
Div pay-date04 Jul 2014

Managed by

Sven Borho Start : 01 Feb 2013
Samuel. D Isaly Start : 28 Apr 1995
Data delayed at least 15 minutes, as of Oct 24 2014 10:04 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.